Principal Securities, Inc. Moderna, Inc. Transaction History
Principal Securities, Inc.
- $4.44 Trillion
- Q4 2024
A detailed history of Principal Securities, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 1,694 shares of MRNA stock, worth $55,885. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,694
Previous 1,764
3.97%
Holding current value
$55,885
Previous $118 Million
40.25%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MRNA
# of Institutions
906Shares Held
246MCall Options Held
18MPut Options Held
21.7M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.33 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.28 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$843 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$580 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$241 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...